Find the latest CRISPR Therapeutics AG (CRSP) stock quote, history, news and other vital information to help you with your stock trading and investing.

Get the latest CRISPR Therapeutics AG (CRSP) stock news and headlines to help you in your trading and investing decisions.

Feb 7, 2025 · In this article, we are going to take a look at where CRISPR Therapeutics AG (NASDAQ:CRSP) stands against the other stocks in Cathie Wood's portfolio.

Find the latest CRISPR Therapeutics AG (CRSP) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors.

Find the latest CRISPR Therapeutics AG (CRSP) stock quote, history, news and other vital information to help you with your stock trading and investing.

5 days ago · CRISPR Therapeutics AG (NASDAQ:CRSP) rose for a fourth day on Friday, ending the day higher by 14.33 percent to finish at $49.72 apiece, as investors cheered its upgraded rating from an investment ...

CRISPR Therapeutics CRSP reported fourth-quarter 2024 loss of 44 cents per share, narrower than the Zacks Consensus Estimate of a loss of $1.15. In the year-ago period, the company recorded ...

CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious human diseases using its Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR ...

Discover historical prices for CRSP stock on Yahoo Finance. View daily, weekly or monthly format back to when CRISPR Therapeutics AG stock was issued.

Feb 7, 2025 · CRISPR Therapeutics CRSP is expected to report fourth-quarter and full-year 2024 earnings later this month. The Zacks Consensus Estimate for quarterly sales is pegged at $10.13 million, while that ...